Here, we further showed that a STING agonist not only promoted anti-tumor M1-like macrophage polarization, but also inhibited pro-tumor macrophage-mediated suppression of synthetic lethality induced by PARPi, thus rendering tumors more susceptible to PARPi therapy. This evidence concerns the gene STING1 and neoplasm.